Unique ID issued by UMIN | UMIN000036493 |
---|---|
Receipt number | R000041581 |
Scientific Title | Verification test of the effectiveness to alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented |
Date of disclosure of the study information | 2019/04/13 |
Last modified on | 2021/04/16 10:33:35 |
Verification test of the effectiveness to alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented
alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented
Verification test of the effectiveness to alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented
alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented
Japan |
Healthy Adult
Adult |
Others
NO
The purpose of this study was to confirm the effectiveness of promoting the alcohol metabolism expected of moromi vinegar lactic acid fermentate.
Efficacy
Blood ethanol, Blood Acetaldehyde
expiration ethanol
Interventional
Cross-over
Randomized
Cluster
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Food |
Moromi lactic acid fermented product containing beverage
Placebo beverage
20 | years-old | <= |
60 | years-old | > |
Male
(1) Adult male at the age of 20 to 60 at the time of obtaining consent
(2) Person who can drink diluted awamori (Alcohol content less than about 30%)
(3) Person who was judged as "thin erythema" or "no erythema" by alcohol patch test
(4) Person who weighs 50.0 kg to 90.0 kg
(5) Persons with physique index (BMI) of 18.5 to 29.9 at the time of obtaining consent
(6) Persons who are judged to have no problem in participation in this study
(7) Persons who obtain written consent to participate in the trial
1) Person who can not drink
(2) Intakes of food and health food that are described as containing ingredients related to the test food: Moromi vinegar
(3) Those who regularly use medicines, health food, food for specified health use, food with functional indication that may affect liver function
(4) Those who regularly take health supplements and supplements related to immune function
(5) Night shift workers and shift workers
(6) At the time of obtaining consent, those who receive treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at medical institutions etc. for treatment or prevention of disease etc. or conditions that require treatment Person to be judged
(7) A person who is deemed to be inappropriate for the study participation
15
1st name | Kondo |
Middle name | |
Last name | Sumio |
Medical Corporation Kenshokai
Fukushima Healthcare Center
553-0004
2-12-13, Tamagawa Fukushima-ku, Osaka, Japan
06-6882-1130
s.kondo@drc-web.co.jp
1st name | Uema |
Middle name | |
Last name | Tyoryo |
ISHIKAWA SHUZOJO Co. Ltd.
Production department
903-0103
Onaha 1438-1, Nishihara Town, Nakagami-Gun, Okinawa, Japan
098-945-3515
uemac@kamejikomi.com
Medical Corporation Kenshokai
ISHIKAWA SHUZOJO Co. Ltd.
Self funding
Brain Care Clinic Ethics Review Committee
Samon-Cho13, Isobe Build. 2F, Shinjyuku-ku, Tokyo
03-3351-3386
yuyosei@drc-web.co.jp
NO
2019 | Year | 04 | Month | 13 | Day |
Unpublished
Delay expected |
Delay Statics Analysis
Completed
2019 | Year | 01 | Month | 19 | Day |
2019 | Year | 03 | Month | 19 | Day |
2019 | Year | 04 | Month | 13 | Day |
2019 | Year | 05 | Month | 31 | Day |
2019 | Year | 04 | Month | 13 | Day |
2021 | Year | 04 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041581
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |